HomeSarilumabSarilumab + Mao Inhibitors

Does Sarilumab Interact with Mao Inhibitors?

Sarilumab and Mao Inhibitors have a unknown drug interaction according to U.S. FDA drug labeling data. KEVZARA has not been investigated in combination with JAK inhibitors; concomitant use not studied. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Sarilumab Class
Interleukin-6 Receptor Antagonist
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Sarilumab and your doctor is considering prescribing Mao Inhibitors (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Sarilumab(Kevzara)+💊 Mao Inhibitors

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Interleukin-6 Receptor Antagonist
Drug B class
Source
NLP:sarilumab

What this means in plain English

KEVZARA has not been investigated in combination with JAK inhibitors; concomitant use not studied.

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Sarilumab and Mao Inhibitors against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.